Literature DB >> 29666049

M1 and M2 macrophages differentially regulate hematopoietic stem cell self-renewal and ex vivo expansion.

Yi Luo1,2, Lijian Shao1, Jianhui Chang1, Wei Feng1, Y Lucy Liu3, Michele H Cottler-Fox4, Peter D Emanuel3, Martin Hauer-Jensen1, Irwin D Bernstein5, Lingbo Liu6, Xing Chen2, Jianfeng Zhou2, Peter J Murray7,8,9, Daohong Zhou1,10.   

Abstract

Uncovering the cellular and molecular mechanisms by which hematopoietic stem cell (HSC) self-renewal is regulated can lead to the development of new strategies for promoting ex vivo HSC expansion. Here, we report the discovery that alternative (M2)-polarized macrophages (M2-MΦs) promote, but classical (M1)-polarized macrophages (M1-MΦs) inhibit, the self-renewal and expansion of HSCs from mouse bone marrow (BM) in vitro. The opposite effects of M1-MΦs and M2-MΦs on mouse BM HSCs were attributed to their differential expression of nitric oxide synthase 2 (NOS2) and arginase 1 (Arg1), because genetic knockout of Nos2 and Arg1 or inhibition of these enzymes with a specific inhibitor abrogated the differential effects of M1-MΦs and M2-MΦs. The opposite effects of M1-MΦs and M2-MΦs on HSCs from human umbilical cord blood (hUCB) were also observed when hUCB CD34+ cells were cocultured with M1-MΦs and M2-MΦs generated from hUCB CD34- cells. Importantly, coculture of hUCB CD34+ cells with human M2-MΦs for 8 days resulted in 28.7- and 6.6-fold increases in the number of CD34+ cells and long-term SCID mice-repopulating cells, respectively, compared with uncultured hUCB CD34+ cells. Our findings could lead to the development of new strategies to promote ex vivo hUCB HSC expansion to improve the clinical utility and outcome of hUCB HSC transplantation and may provide new insights into the pathogenesis of hematological dysfunctions associated with infection and inflammation that can lead to differential macrophage polarization.
© 2018 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29666049      PMCID: PMC5916005          DOI: 10.1182/bloodadvances.2018015685

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  47 in total

1.  Rapid expansion of human hematopoietic stem cells by automated control of inhibitory feedback signaling.

Authors:  Elizabeth Csaszar; Daniel C Kirouac; Mei Yu; WeiJia Wang; Wenlian Qiao; Michael P Cooke; Anthony E Boitano; Caryn Ito; Peter W Zandstra
Journal:  Cell Stem Cell       Date:  2012-02-03       Impact factor: 24.633

Review 2.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

3.  Development of a vascular niche platform for expansion of repopulating human cord blood stem and progenitor cells.

Authors:  Jason M Butler; Eric J Gars; Daylon J James; Daniel J Nolan; Joseph M Scandura; Shahin Rafii
Journal:  Blood       Date:  2012-06-18       Impact factor: 22.113

Review 4.  Small molecule regulation of normal and leukemic stem cells.

Authors:  Iman Fares; Laura Rivest-Khan; Sandra Cohen; Guy Sauvageau
Journal:  Curr Opin Hematol       Date:  2015-07       Impact factor: 3.284

Review 5.  Making sense of hematopoietic stem cell niches.

Authors:  Philip E Boulais; Paul S Frenette
Journal:  Blood       Date:  2015-03-11       Impact factor: 22.113

6.  Cord-blood engraftment with ex vivo mesenchymal-cell coculture.

Authors:  Marcos de Lima; Ian McNiece; Simon N Robinson; Mark Munsell; Mary Eapen; Mary Horowitz; Amin Alousi; Rima Saliba; John D McMannis; Indreshpal Kaur; Partow Kebriaei; Simrit Parmar; Uday Popat; Chitra Hosing; Richard Champlin; Catherine Bollard; Jeffrey J Molldrem; Roy B Jones; Yago Nieto; Borje S Andersson; Nina Shah; Betul Oran; Laurence J N Cooper; Laura Worth; Muzaffar H Qazilbash; Martin Korbling; Gabriela Rondon; Stefan Ciurea; Doyle Bosque; Ila Maewal; Paul J Simmons; Elizabeth J Shpall
Journal:  N Engl J Med       Date:  2012-12-13       Impact factor: 91.245

7.  Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells.

Authors:  Anthony E Boitano; Jian Wang; Russell Romeo; Laure C Bouchez; Albert E Parker; Sue E Sutton; John R Walker; Colin A Flaveny; Gary H Perdew; Michael S Denison; Peter G Schultz; Michael P Cooke
Journal:  Science       Date:  2010-08-05       Impact factor: 47.728

8.  Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment.

Authors:  Mitchell E Horwitz; Nelson J Chao; David A Rizzieri; Gwynn D Long; Keith M Sullivan; Cristina Gasparetto; John P Chute; Ashley Morris; Carolyn McDonald; Barbara Waters-Pick; Patrick Stiff; Steven Wease; Amnon Peled; David Snyder; Einat Galamidi Cohen; Hadas Shoham; Efrat Landau; Etty Friend; Iddo Peleg; Dorit Aschengrau; Dima Yackoubov; Joanne Kurtzberg; Tony Peled
Journal:  J Clin Invest       Date:  2014-06-09       Impact factor: 14.808

9.  Macrophage arginase-1 controls bacterial growth and pathology in hypoxic tuberculosis granulomas.

Authors:  María A Duque-Correa; Anja A Kühl; Paulo C Rodriguez; Ulrike Zedler; Sandra Schommer-Leitner; Martin Rao; January Weiner; Robert Hurwitz; Joseph E Qualls; George A Kosmiadi; Peter J Murray; Stefan H E Kaufmann; Stephen T Reece
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-08       Impact factor: 11.205

10.  Macrophages contribute to the cyclic activation of adult hair follicle stem cells.

Authors:  Donatello Castellana; Ralf Paus; Mirna Perez-Moreno
Journal:  PLoS Biol       Date:  2014-12-23       Impact factor: 8.029

View more
  15 in total

1.  Plasma Cells Are Obligate Effectors of Enhanced Myelopoiesis in Aging Bone Marrow.

Authors:  Peter D Pioli; David Casero; Encarnacion Montecino-Rodriguez; Sherie L Morrison; Kenneth Dorshkind
Journal:  Immunity       Date:  2019-07-11       Impact factor: 31.745

Review 2.  Targeting the Hematopoietic Stem Cell Niche in β-Thalassemia and Sickle Cell Disease.

Authors:  Annamaria Aprile; Silvia Sighinolfi; Laura Raggi; Giuliana Ferrari
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-11

Review 3.  Recent Advancements in Poor Graft Function Following Hematopoietic Stem Cell Transplantation.

Authors:  Yan Man; Zhixiang Lu; Xiangmei Yao; Yuemin Gong; Tonghua Yang; Yajie Wang
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

4.  Reference gene selection and validation for mRNA expression analysis by RT-qPCR in murine M1- and M2-polarized macrophage.

Authors:  Wen Ju; Tiantian Sun; Wenyi Lu; Alhaji Osman Smith; Yurong Bao; Seyram Yao Adzraku; Kunming Qi; Kailin Xu; Jianlin Qiao; Lingyu Zeng
Journal:  Mol Biol Rep       Date:  2020-03-19       Impact factor: 2.316

Review 5.  Magnetic resonance imaging of stem cell-macrophage interactions with ferumoxytol and ferumoxytol-derived nanoparticles.

Authors:  Hossein Nejadnik; Jessica Tseng; Heike Daldrup-Link
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-02-07

Review 6.  The Role of Maresins in Inflammatory Pain: Function of Macrophages in Wound Regeneration.

Authors:  Sung-Min Hwang; Gehoon Chung; Yong Ho Kim; Chul-Kyu Park
Journal:  Int J Mol Sci       Date:  2019-11-21       Impact factor: 5.923

7.  CD14+ monocytes repress gamma globin expression at early stages of erythropoiesis.

Authors:  Steven Heshusius; Esther Heideveld; Marieke von Lindern; Emile van den Akker
Journal:  Sci Rep       Date:  2021-01-15       Impact factor: 4.379

8.  Nitric Oxide in the Control of the in vitro Proliferation and Differentiation of Human Hematopoietic Stem and Progenitor Cells.

Authors:  Julia Hümmer; Saskia Kraus; Katharina Brändle; Cornelia Lee-Thedieck
Journal:  Front Cell Dev Biol       Date:  2021-02-09

Review 9.  M2 Macrophages Serve as Critical Executor of Innate Immunity in Chronic Allograft Rejection.

Authors:  Hanwen Zhang; Zhuonan Li; Wei Li
Journal:  Front Immunol       Date:  2021-03-17       Impact factor: 7.561

Review 10.  Macrophages Orchestrate Hematopoietic Programs and Regulate HSC Function During Inflammatory Stress.

Authors:  Allison N Seyfried; Jackson M Maloney; Katherine C MacNamara
Journal:  Front Immunol       Date:  2020-07-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.